ANNEXON BIOSCIENCES

annexon-biosciences-logo

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The companyโ€™s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The companyโ€™s first product... candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The companyโ€™s second product candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish that its product candidates are engaging the target at a well-tolerated therapeutic dose in the intended patient tissue.

#SimilarOrganizations #People #Financial #Event #Website #More

ANNEXON BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Life Science Therapeutics

Founded:
2011-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.annexonbio.com

Total Employee:
101+

Status:
Active

Contact:
(650)822-5500

Email Addresses:
[email protected]

Total Funding:
384 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving


Similar Organizations

sagimet-biosciences-logo

Sagimet Biosciences

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

kezar-life-sciences-logo

Kezar Life Sciences

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

arnon-rosenthal_image

Arnon Rosenthal Chairman of the Board of Directors @ Annexon Biosciences
Board_member
2011-08-01

frank-torti_image

Frank Torti Board of Directors @ Annexon Biosciences
Board_member

ricky-sun_image

Ricky Sun Board Member @ Annexon Biosciences
Board_member
2018-12-01

Current Employees Featured

jennifer-lew_image

Jennifer Lew
Jennifer Lew EVP & CFO @ Annexon Biosciences
EVP & CFO

michael-overdorf_image

Michael Overdorf
Michael Overdorf Executive Vice President and Chief Business Officer @ Annexon Biosciences
Executive Vice President and Chief Business Officer

ted-yednock_image

Ted Yednock
Ted Yednock EVP & CIO @ Annexon Biosciences
EVP & CIO
2021-09-01

larry-c-mattheakis_image

Larry C. Mattheakis
Larry C. Mattheakis CSO @ Annexon Biosciences
CSO
2021-09-01

eric-humphriss_image

Eric Humphriss
Eric Humphriss Vice President, Global Clinical Operations @ Annexon Biosciences
Vice President, Global Clinical Operations
2018-10-01

douglas-love_image

Douglas Love
Douglas Love President & Chief Executive Officer @ Annexon Biosciences
President & Chief Executive Officer
2014-12-01

Founder


arnon-rosenthal_image

Arnon Rosenthal

not_available_image

Ben Barres

Stock Details


Company's stock symbol is NASDAQ:ANNX

Investors List

satter-investment-management_image

Satter Investment Management

Satter Investment Management investment in Post-IPO Equity - Annexon Biosciences

fairmount-funds-management_image

Fairmount Funds Management

Fairmount Funds Management investment in Post-IPO Equity - Annexon Biosciences

driehaus-capital-management_image

Driehaus Capital Management

Driehaus Capital Management investment in Post-IPO Equity - Annexon Biosciences

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Post-IPO Equity - Annexon Biosciences

venrock-healthcare-partners_image

Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners investment in Post-IPO Equity - Annexon Biosciences

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Post-IPO Equity - Annexon Biosciences

redmile-group_image

Redmile Group

Redmile Group investment in Post-IPO Equity - Annexon Biosciences

satter-investment-management_image

Satter Investment Management

Satter Investment Management investment in Series C - Annexon Biosciences

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Annexon Biosciences

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series C - Annexon Biosciences

Official Site Inspections

http://www.annexonbio.com Semrush global rank: 7.31 M Semrush visits lastest month: 528

  • Host name: 41.102.145.34.bc.googleusercontent.com
  • IP address: 34.145.102.41
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Annexon Biosciences" on Search Engine